People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zyus Life Sciences Inc. | — | Other Health Care | Series B | $40.4M | $10.4M | 2020 |
| CanniMed Therapeutics Inc. | — | Biotechnology | Series A | $5.2M | $186.3M | 2016 |
Donald Ching at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Ching on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Knowles | 2 | 4 |
| Richard Hoyt | 2 | 3 |
| Larry Holbrook | 2 | 2 |
| Brandon Price | 1 | 4 |
| Brent Zettl | 1 | 4 |
| Keith Carpenter | 1 | 3 |
| John Hyshka | 1 | 3 |
| Michelle Gursky | 1 | 2 |
| Garnette Weber | 1 | 2 |
| Dwayne Lashyn | 1 | 2 |
| Marianne Greer | 1 | 2 |
| Rob Duguid | 1 | 2 |
| Bruce Mackler | 1 | 2 |
| Doug Banzet | 1 | 1 |
| Gulwant Bajwa | 1 | 1 |
| Dr. Lionel Marks De Chabris | 1 | 1 |
| Rob Harding | 1 | 1 |
| Brenton Zettl | 1 | 1 |
| Adam Darbellay | 1 | 1 |
| Allan Fowler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.